Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Rational Management Approach To Pure Red Cell Aplasia

    ... in hypogammaglobulinemia cases. In salvage settings, alemtuzumab is active, particularly in large granular lymphocytic leukemia ... salvage agents such as intravenous immunoglobulin, alemtuzumab and bortezomib. LINK to Journal ...

    Research Article last updated 12/14/2017 - 10:12am.

  2. Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) (CHAMP)

    ... Protocol Chairs and/or Protocol Officer. Alemtuzumab or ATG within 2 weeks of enrollment ...

    Clinical Trial last updated 12/19/2017 - 7:55am.

  3. A Rare Case of Aplastic Anemia Later in Life Doesn’t Stop Al Meyer

    ... stem cell transplant . So that’s when I was put on alemtuzumab (Campath®), which I had no response to.  So in late 2013, ...

    Patient Chronicle last updated 07/12/2017 - 1:52pm.

  4. Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm

    ... therapy, including the anti-CD52 antibody alemtuzumab . We analyzed treatment responses to alemtuzumab in 5 patients with MDS or aplastic anemia (AA) evolving to MDS. ...

    Research Article last updated 11/01/2016 - 1:56pm.

  5. Eltrombopag for the treatment of aplastic anemia: current perspectives

    ... globulin, high-dose cyclophosphamide , and alemtuzumab . Eltrombopag, a thrombopoietin mimetic, has recently emerged as ...

    Research Article last updated 11/01/2016 - 2:01pm.

  6. Alemtuzumab

    ... Alemtuzumab is a drug used in the treatment of chronic lymphocytic ... which these lymphocytes are derived. After treatment with alemtuzumab, these CD52-bearing lymphocytes are targeted for destruction. ...

    Drug last updated 03/26/2016 - 8:15pm.

  7. Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

    ... be given on study is fludarabine , melphalan, and alemtuzumab . These drugs are designed to stop the growth of cancer cells, ... mg/m2 by vein on Day -2. Other Name: Alkeran Drug: Alemtuzumab 50 mg by vein on Day -1. Other Names: ...

    Clinical Trial last updated 06/06/2016 - 12:41pm.

  8. Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

    ... Planned use of anti-thymocyte globulin (ATG) or alemtuzumab in conditioning regimen. Planned post-transplant therapy, ...

    Clinical Trial last updated 06/06/2016 - 1:59pm.

  9. Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT (RIC HSCT NMD)

    ... Associated Drug(s):  Alemtuzumab Fludarabine ...

    Clinical Trial last updated 06/13/2016 - 2:18pm.

  10. Myelodysplastic Syndromes and autoimmune disorders: Cause or consequence?

    ... (ImiDs), antithymocyte globulin (ATG), and alemtuzumab ) due to the autoimmune component. ...

    Research Review last updated 05/02/2016 - 9:18am.